NCT03610906Enrolling by invitation
Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 17 Jul 2018
- Start date
- 12 Mar 2019
- Primary completion date
- 2 Feb 2030
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Childhood cancers
- NCT number
- NCT03610906
What you commit to
- Study type: Observational
- Planned participants: 250
- From 12 Mar 2019 to the primary completion date, 2 Feb 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients over 21 years of age.
Other
- Patients in whom final pathology does not demonstrate adamantinomatous craniopharyngioma
- Patients in whom tissue specimen is not obtained/available
- Patients who choose not to participate
Who the study is looking for
- Patients between 0-21 years of age.
- Patients with the diagnosis or clinical suspicion of craniopharyngioma in whom planned clinical management will include tissue sampling.
Age in the registry: 30 days to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital Colorado Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.